Kerecis is a biotechnology company that makes advanced wound care products, including fish-skin–derived skin substitutes. Its filings show it lobbies Congress to educate lawmakers about advanced wound care technologies and to improve patient access to skin substitutes. The company hired the firm Invariant LLC and reported about $250,000 in lobbying since 2026 filings began.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DREW GRIFFIN
The latest disclosures for this client.
INVARIANT LLC
Q1INVARIANT LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
INVARIANT LLC
JESSICA POWELL
INVARIANT LLC
ms ANNABELL MCWHERTER STOKES
INVARIANT LLC
JESSICA HATCHER
INVARIANT LLC
JEFFREY LUNGREN
INVARIANT LLC
ANNABELL STOKES
INVARIANT LLC
BENJAMIN KLEIN
INVARIANT LLC
KATHRYN WISE
INVARIANT LLC
INVARIANT LLC
Q3INVARIANT LLC
Q2INVARIANT LLC
Q1